Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.

Jo M, Takimoto S, Montel V, Gonias SL.

Am J Pathol. 2009 Jul;175(1):190-200. doi: 10.2353/ajpath.2009.081053. Epub 2009 Jun 4.

2.

A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.

Liu D, Zhou D, Wang B, Knabe WE, Meroueh SO.

ACS Chem Biol. 2015 Jun 19;10(6):1521-34. doi: 10.1021/cb500832q. Epub 2015 Mar 31.

3.
4.

Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.

Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.

J Cell Physiol. 2005 Jul;204(1):73-82.

PMID:
15573379
5.
6.
8.

TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.

Sugioka K, Kodama A, Okada K, Iwata M, Yoshida K, Kusaka S, Matsumoto C, Kaji H, Shimomura Y.

Exp Eye Res. 2013 Oct;115:13-21. doi: 10.1016/j.exer.2013.06.020. Epub 2013 Jun 28.

PMID:
23810810
9.

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.

Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.

Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.

PMID:
21833477
10.
11.

SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.

Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS.

Int J Oncol. 2006 Dec;29(6):1349-57.

12.

Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.

Hattori N, Sisson TH, Xu Y, Desai TJ, Simon RH.

Am J Physiol. 1999 Sep;277(3 Pt 1):L573-9.

13.

The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.

Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C, McKeown-Longo PJ.

Matrix Biol. 2007 Jun;26(5):359-70. Epub 2007 Feb 6.

PMID:
17344041
15.

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.

Cancer Res. 2005 Sep 1;65(17):7775-81.

16.
17.
18.

Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.

Connolly BM, Choi EY, Gårdsvoll H, Bey AL, Currie BM, Chavakis T, Liu S, Molinolo A, Ploug M, Leppla SH, Bugge TH.

Blood. 2010 Sep 2;116(9):1593-603. doi: 10.1182/blood-2010-03-276642. Epub 2010 May 13.

19.

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.

Cancer Gene Ther. 2000 Feb;7(2):292-9.

20.

N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.

Whyte C, Thies F, Peyrol L, Balcerzak D.

J Nutr Biochem. 2012 Nov;23(11):1378-83. doi: 10.1016/j.jnutbio.2011.08.005. Epub 2012 Jan 4.

PMID:
22221673

Supplemental Content

Support Center